(MedPage Today) — Long-term removal of amyloid beta in people genetically destined to develop Alzheimer’s disease may have delayed symptoms and disease progression, data from the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) suggested…
Source link : https://www.medpagetoday.com/neurology/alzheimersdisease/114764
Author :
Publish date : 2025-03-20 21:19:00
Copyright for syndicated content belongs to the linked Source.